These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21905064)

  • 1. The benefit of stratification in clinical trials revisited.
    Ganju J; Zhou K
    Stat Med; 2011 Oct; 30(24):2881-9. PubMed ID: 21905064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The large sample bounds on the principal strata effect with application to a prostate cancer prevention trial.
    Chiba Y
    Int J Biostat; 2012 May; 8(1):Article 12. PubMed ID: 22628357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size calculation for multicenter randomized trial: taking the center effect into account.
    Vierron E; Giraudeau B
    Contemp Clin Trials; 2007 Jul; 28(4):451-8. PubMed ID: 17188941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.
    Quan H; Li M; Shih WJ; Ouyang SP; Chen J; Zhang J; Zhao PL
    Stat Med; 2013 May; 32(10):1691-706. PubMed ID: 22855311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of unstratified and centre-stratified randomization in multi-centre clinical trials.
    Anisimov VV
    Pharm Stat; 2011; 10(1):50-9. PubMed ID: 20112277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size allocation to regions in a multiregional trial.
    Uesaka H
    J Biopharm Stat; 2009 Jul; 19(4):580-94. PubMed ID: 20183427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of multiregional trials with heterogeneous treatment effect across regions.
    Chen CT; Hung HM; Hsiao CF
    J Biopharm Stat; 2012 Sep; 22(5):1037-50. PubMed ID: 22946948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials.
    van Breukelen GJ; Candel MJ; Berger MP
    Stat Med; 2007 Jun; 26(13):2589-603. PubMed ID: 17094074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analysis of continuous outcomes in multi-centre trials with small centre sizes.
    Pickering RM; Weatherall M
    Stat Med; 2007 Dec; 26(30):5445-56. PubMed ID: 17924360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficiency of randomization methods that balance on stratum margins and improvements with permuted blocks and a sequential method.
    Kaiser LD
    Stat Med; 2012 Jul; 31(16):1699-706. PubMed ID: 22437508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of rank-based procedures for multicenter clinical trials.
    Rashid MM; McKean JW; Kloke JD
    J Biopharm Stat; 2013; 23(6):1207-27. PubMed ID: 24138428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population enrichment designs: case study of a large multinational trial.
    Mehta CR; Gao P
    J Biopharm Stat; 2011 Jul; 21(4):831-45. PubMed ID: 21516572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-estimating the sample size of an on-going blinded trial based on the method of randomization block sums.
    Ganju J; Xing B
    Stat Med; 2009 Jan; 28(1):24-38. PubMed ID: 18837073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient treatment allocation in 2 × 2 multicenter trials when costs and variances are heterogeneous.
    Lemme F; van Breukelen GJP; Candel MJJM
    Stat Med; 2018 Jan; 37(1):12-27. PubMed ID: 28948651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method to estimate the variance of an endpoint from an on-going blinded trial.
    Xing B; Ganju J
    Stat Med; 2005 Jun; 24(12):1807-14. PubMed ID: 15803440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demystifying optimal dynamic treatment regimes.
    Moodie EE; Richardson TS; Stephens DA
    Biometrics; 2007 Jun; 63(2):447-55. PubMed ID: 17688497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the treatment difference in multicenter trials.
    Fedorov V; Jones B; Jones M; Zhigljavsky A
    J Biopharm Stat; 2004 Nov; 14(4):1037-63. PubMed ID: 15587979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ; Miner M
    Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.